Roche (JOBS) Antiviral Meets Main Goal in Late-Stage Study Published: Feb 17, 2009 Feb 13 (Reuters) - Swiss drugmaker Roche Holding AG said its already approved antiviral Valcyte, met the main goal of a late-stage study. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news